Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Long-Term Debt Repayments (2016 - 2025)

vTv Therapeutics (VTVT) has disclosed Long-Term Debt Repayments for 11 consecutive years, with $328000.0 as the latest value for Q4 2025.

  • Quarterly Long-Term Debt Repayments changed N/A to $328000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $392000.0 through Dec 2025, up 105.24% year-over-year, with the annual reading at $392000.0 for FY2025, 105.24% up from the prior year.
  • Long-Term Debt Repayments hit $328000.0 in Q4 2025 for vTv Therapeutics, up from $64000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $380000.0 in Q4 2021 to a low of $64000.0 in Q3 2025.
  • Historically, Long-Term Debt Repayments has averaged $225416.7 across 5 years, with a median of $237500.0 in 2021.
  • Biggest five-year swings in Long-Term Debt Repayments: plummeted 95.36% in 2021 and later surged 204.76% in 2022.
  • Year by year, Long-Term Debt Repayments stood at $380000.0 in 2021, then dropped by 12.37% to $333000.0 in 2022, then fell by 15.32% to $282000.0 in 2023, then tumbled by 32.27% to $191000.0 in 2024, then surged by 71.73% to $328000.0 in 2025.
  • Business Quant data shows Long-Term Debt Repayments for VTVT at $328000.0 in Q4 2025, $64000.0 in Q3 2025, and $191000.0 in Q1 2024.